Skip to main content Accessibility help
×
Home

‘Leptorapide’ – a one-step assay for rapid diagnosis of human leptospirosis

  • T. BROWNLOW (a1), O. V. KAVANAGH (a1) (a2), E. F. LOGAN (a1), R. A. HARTSKEERL (a3), R. SAVAGE (a1), M. F. PALMER (a4), M. KRAHL (a5), D. P. MACKIE (a5) and W. A. ELLIS (a6)...

Summary

Leptospirosis is a globally important zoonotic infection caused by spirochaetes of the genus Leptospira. It is transmitted to humans by direct contact with infected animals or indirectly via contaminated water. It is mainly a problem of the resource-poor developing countries of the tropical and sub-tropical regions of the world but outbreaks due to an increase in travel and recreational activities have been reported in developed and more industrialized areas of the world. Current methods of diagnosis are costly, time-consuming and require the use of specialized laboratory equipment and personnel. The purpose of this paper is to report the validation of the ‘Leptorapide®’ test (Linnodee Ltd, Northern Ireland) for the diagnosis of human leptospirosis. It is a simple one-step latex agglutination assay performed using equal volumes of serum sample and antigen-bound latex beads. Evidence of leptospiral antibodies is determined within minutes. Agglutination is scored on a scale of 1–5 and the results interpreted using a score card provided with the kit. Validation has been performed with a large sample size obtained from individuals originating from various parts of the world including Brazil and India. The test has shown sensitivity and specificity values of 97·1% and 94·0%, respectively, relative to the microscopic agglutination test. The results demonstrate that Leptorapide offers a cost-effective and accurate alternative to the more historical methods of antibody detection.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      ‘Leptorapide’ – a one-step assay for rapid diagnosis of human leptospirosis
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      ‘Leptorapide’ – a one-step assay for rapid diagnosis of human leptospirosis
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      ‘Leptorapide’ – a one-step assay for rapid diagnosis of human leptospirosis
      Available formats
      ×

Copyright

Corresponding author

* Author for correspondence: Mrs T. Brownlow, Linnodee Ltd, Holestone Road, Ballyclare, BT39 OTJ, Northern Ireland. (Email: info@linnodee.com)

References

Hide All
1. Vijayachari, P, Sugunan, AP, Shriram, AN. Leptospirosis: an emerging global public health problem. Journal of Biosciences 2008; 33: 557569.
2. Victoriano, AF, et al. Leptospirosis in the Asia Pacific region. BioMed Central Infectious Diseases. Published online 4 September 2009 . doi:10.1186/1471-2334-9-147.
3. Pappas, G, et al. The globalization of leptospirosis: worldwide incidence trends. International Journal of Infectious Diseases 2008; 12: 351357.
4. WHO. Leptospirosis worldwide. Weekly Epidemiological Record 1999; 74: 237242.
5. Adler, B, de la Pena Moctezuma, A. Leptospira and leptospirosis. Veterinary Microbiology 2010; 140: 287296.
6. Karaseva, EV, Chernukha, YG, Piskunova, LA. Results of studying the time of survival of pathogenic leptospira under natural conditions. Journal of Hygiene, Epidemiology, Microbiology and Immunology 1973; 17: 339345.
7. Ganoza, CA, et al. Asymptomatic renal colonization of humans in the peruvian Amazon by Leptospira. PLoS Neglected Tropical Diseases 2010; 4: 612.
8. Trueba, G, et al. Cell aggregation: a mechanism of pathogenic Leptospira to survive in fresh water. International Microbiology 2004; 7: 3540.
9. Benschop, J, et al. Seroprevalence of leptospirosis in workers at a New Zealand slaughterhouse. New Zealand Medical Journal 2009; 122: 3947.
10. Levett, PN. Leptospirosis. Clinical Microbiology Reviews 2001; 14: 296326.
11. Dolhnikoff, M, et al. Pathology and pathophysiology of pulmonary manifestations in leptospirosis. Brazilian Journal of Infectious Diseases 2007; 11: 142148.
12. de Albuquerque Filho, AP, et al. Validation of a case definition for leptospirosis diagnosis in patients with acute severe febrile disease admitted in reference hospitals at the State of Pernambuco, Brazil. Revista da Sociedade Brasileira de Medicina Tropical 2011; 44: 735739.
13. Smythe, LD, et al. The microscopic agglutination test (MAT) is an unreliable predictor of infecting Leptospira serovar in Thailand. American Journal of Tropical Medicine and Hygiene 2009; 81: 695697.
14. Ahmad, SN, Shah, S, Ahmad, FM. Laboratory diagnosis of leptospirosis. Journal of Postgraduate Medicine, 2005; 51: 195200.
15. Wolff, JW. The Laboratory Diagnosis of Leptospirosis. The University of Michigan: C. C. Thomas, 1954.
16. Palmer, MF, Waitkins, SA, Wanyangu, SW. A comparison of live and formalised leptospiral microscopic agglutination test. Zentralblatt fur Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology 1987; 265: 151159.
17. Zochowski, WJ, Palmer, MF, Coleman, TJ. An evaluation of three commercial kits for use as screening methods for the detection of leptospiral antibodies in the UK. Journal of Clinical Pathology 2001; 54: 2530.
18. Pappas, MG, et al. Rapid serodiagnosis of leptospirosis using the IgM-specific Dot-ELISA: comparison with the microscopic agglutination test. American Journal of Tropical Medicine and Hygiene 1985; 34: 346354.
19. Winslow, WE, et al. Evaluation of a commercial enzyme-linked immunosorbent assay for detection of immunoglobulin M antibody in diagnosis of human leptospiral infection. Journal of Clinical Microbiology 1997; 35: 19381942.
20. Ribeiro, MA, Souza, CC, Almeida, SH. Dot-ELISA for human leptospirosis employing immunodominant antigen. American Journal of Tropical Medicine and Hygiene 1995; 98: 452456.
21. Brandao, AP, et al. Macroscopic agglutination test for rapid diagnosis of human leptospirosis. Journal of Clinical Microbiology 1998; 36: 31383142.

Keywords

Related content

Powered by UNSILO
Type Description Title
WORD
Supplementary materials

Brownlow Supplementary Material
Appendix

 Word (1.2 MB)
1.2 MB
WORD
Supplementary materials

Brownlow Supplementary Material
Table

 Word (37 KB)
37 KB
WORD
Supplementary materials

Brownlow Supplementary Material
Table

 Word (17 KB)
17 KB

‘Leptorapide’ – a one-step assay for rapid diagnosis of human leptospirosis

  • T. BROWNLOW (a1), O. V. KAVANAGH (a1) (a2), E. F. LOGAN (a1), R. A. HARTSKEERL (a3), R. SAVAGE (a1), M. F. PALMER (a4), M. KRAHL (a5), D. P. MACKIE (a5) and W. A. ELLIS (a6)...

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.